# Clinical Study of Individualized Treatment of Relapsed or Drug-resistant Advanced Gynecological Tumors Guided by PTC Model

> **NCT06232213** · — · RECRUITING · sponsor: **Hua Li** · enrollment: 40 (estimated)

## Conditions studied

- Personalized Cancer Treatment

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06232213
- **Lead sponsor:** Hua Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06232213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06232213, "Clinical Study of Individualized Treatment of Relapsed or Drug-resistant Advanced Gynecological Tumors Guided by PTC Model". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06232213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*